Seaport Res Ptn Lowers Earnings Estimates for Ayr Wellness

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Seaport Res Ptn reduced their Q1 2025 earnings per share estimates for Ayr Wellness in a research note issued on Sunday, March 9th. Seaport Res Ptn analyst S. Randhawa now expects that the company will post earnings per share of ($0.27) for the quarter, down from their prior forecast of ($0.24). The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.31) per share. Seaport Res Ptn also issued estimates for Ayr Wellness’ Q2 2025 earnings at ($0.25) EPS, Q3 2025 earnings at ($0.24) EPS, Q4 2025 earnings at ($0.23) EPS and FY2025 earnings at ($0.99) EPS.

A number of other analysts have also recently commented on the stock. Roth Mkm dropped their target price on shares of Ayr Wellness from $3.50 to $3.00 and set a “buy” rating on the stock in a report on Thursday, November 14th. Atb Cap Markets cut shares of Ayr Wellness from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 13th.

Ayr Wellness Stock Performance

Shares of AYRWF stock opened at $0.16 on Wednesday. Ayr Wellness has a 12 month low of $0.16 and a 12 month high of $3.46. The stock has a market cap of $18.47 million, a PE ratio of -0.07 and a beta of 1.70. The company has a current ratio of 1.59, a quick ratio of 0.58 and a debt-to-equity ratio of 0.76. The company’s fifty day moving average price is $0.42 and its 200-day moving average price is $1.03.

Ayr Wellness (OTCMKTS:AYRWF) last announced its quarterly earnings data on Thursday, March 6th. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.29) by ($0.12). Ayr Wellness had a negative net margin of 48.17% and a negative return on equity of 25.30%. The firm had revenue of $113.96 million for the quarter, compared to analysts’ expectations of $114.10 million.

Ayr Wellness Company Profile

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.